Close this search box.

Sensus Healthcare Receives the BioFlorida Company of the Year Award

December 13, 2016

BOCA RATON, Fla., Dec. 13, 2016 — Sensus Healthcare, Inc. (NASDAQ: SRTS), a medical device company specializing in the treatment of non-melanoma skin cancers (NMSC) and other skin conditions such as keloids with superficial radiation therapy (SRT), announced today that it has been named the winner of the BioFlorida Company of the Year Award at the 2016 BioFlorida Annual Conference in Jacksonville, Florida.

“We are honored to receive the BioFlorida Company of the Year Award,” said Joe Sardano, Chief Executive Officer of Sensus Healthcare. “2016 has been especially exciting for us as a company. To name a few milestones, we successfully completed our initial public offering in June, more than doubled our salesforce, expanded our global reach and increased sales 54 percent year-over-year all in the first nine months of the year.”

“We launched Sensus Healthcare in 2010 with the goal to develop and market advanced medical devices that would allow the company to achieve two goals: address large and underserved market opportunities within the medical device arena and offer a disruptive and compelling value proposition to physicians and patients alike. Our SRT therapy treatment devices are virtually painless; do not require anesthesia, cutting, or stitching; do not result in bleeding or scarring; and are cost effective. We are committed to bringing innovative solutions to the State of Florida and globally,” concluded Mr. Sardano.

The BioFlorida Annual Conference brings together hundreds of life science professionals and showcases recent scientific advancements, business achievements and public policy issues. Attendees gather to hear about the industry’s significant growth across the state of Florida. Prominent keynote speakers at the 2016 conference included: Jason Altmire, SVP of Public Policy and Community Engagement, Florida Blue; Peter Menziuso, President, North America, Johnson & Johnson Vision Care; James A. Rogers III, J.D., Chair, Mayo Clinic Ventures, Deputy Director, Center for Regenerative Medicine.

“As the voice of Florida’s life sciences industry, we are proud to award Sensus Healthcare with the BioFlorida Company of the Year. As the only Florida based company to complete an initial public offering in 2016, the unique technology that Sensus brings to the market could not be a better representation of the innovation we recognize and foster in Florida,” said Nancy Bryan, President and CEO of BioFlorida.

About BioFlorida

BioFlorida is the voice of Florida’s life sciences industry, representing nearly 6,000 establishments and research organizations in the biotechnology, pharmaceuticals, medical technology (devices and diagnostics) and bioagriculture sectors that collectively employ nearly 83,000 Floridians (Source: The Value of Bioscience Innovation in Growing Jobs and Improving Quality of Life, TEConomy/BIO, 2016). Members of the BioFlorida network include emerging and established life science companies, universities, research institutions, hospitals, medical centers, incubators, economic development agencies, investors and service providers.

About Sensus

Sensus Healthcare, Inc. is a medical device company that is committed to enabling non-invasive and cost-effective treatment of non-melanoma skin cancers and keloids. Sensus uses a proprietary low energy x-ray radiation technology known as superficial radiation therapy (SRT), which is a result of over a decade of dedicated research and development activities. Sensus has successfully incorporated the SRT therapy into its portfolio of treatment devices, the SRT-100™ and SRT-100 Vision™. To date, the SRT technology has been used to effectively and safely treat oncological and non-oncological skin conditions in thousands of patients. For more information, visit

Investor Relations:
Jeffrey Goldberger / Allison Soss
KCSA Strategic Communications
Phone: 212-896-1249 / 212-896-1267
Email: [email protected] / [email protected]

To view the original version on PR Newswire, visit:

SOURCE Sensus Healthcare, Inc.